Finance

Beta
Lists
3613:HKG
Beijing Tong Ren Tang Chinese Medicine
HK$7.03
+4.46%
(+0.30) 1D
Jul 16, 4:08:32 PM GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 3613...
Open
HK$6.76
High
HK$7.03
Low
HK$6.76
Mkt. cap
5.88B
Avg. vol.
892.17K
Volume
1.35M
Dividend
5.26%
Quarterly dividend
HK$0.09
Ex-dividend date
Jun 12, 2026
P/E ratio
14.82
52-wk high
HK$9.72
52-wk low
HK$6.21
EPS
HK$0.47
Shares outstanding
837.10M
No. of employees
780
Open
HK$6.76
High
HK$7.03
Low
HK$6.76
Mkt. cap
5.88B
Avg. vol.
892.17K
Volume
1.35M
Dividend
5.26%
Quarterly dividend
HK$0.09
Ex-dividend date
Jun 12, 2026
P/E ratio
14.82
52-wk high
HK$9.72
52-wk low
HK$6.21
EPS
HK$0.47
Shares outstanding
837.10M
No. of employees
780
News stories
From sources across the web
About Beijing Tong Ren Tang Chinese Medicine
CEO-
Employees780
Founded1669
Headquarters-
SectorPharmaceutical industry
Last report
Mar 20, 2026
Fiscal period
Q4 2025
EPS / Est. (HKD)
- / -
Revenue / Est. (HKD)
375.81M / -
Fiscal Q4 2025 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in HKD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in HKD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
380.87M
380.87M
375.81M
375.81M
Cost of goods sold
149.35M
149.35M
144.54M
144.54M
Cost of revenue
149.35M
149.35M
144.54M
144.54M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
95.65M
95.65M
99.56M
99.56M
Operating expense
98.85M
98.85M
125.94M
125.94M
Total operating expenses
248.20M
248.20M
270.48M
270.48M
Operating income
132.67M
132.67M
105.33M
105.33M
Other non operating income
-
-
-
-
EBT including unusual items
144.84M
144.84M
107.51M
107.51M
EBT excluding unusual items
144.84M
144.84M
109.49M
109.49M
Income tax expense
21.87M
21.87M
22.05M
22.05M
Effective tax rate
15.10%
15.10%
20.51%
20.51%
Other operating expenses
-468.50K
-468.50K
-741.00K
-741.00K
Net income
117.43M
117.43M
81.18M
81.18M
Net profit margin
30.83%
30.83%
21.60%
21.60%
Earnings per share
-
-
-
-
Interest and investment income
13.76M
13.76M
9.76M
9.76M
Interest expense
-1.69M
-1.69M
-1.14M
-1.14M
Net interest expenses
12.07M
12.07M
8.62M
8.62M
Depreciation and amortization charges
-
-
-
-
EBITDA
137.39M
137.39M
110.37M
110.37M
Gain or loss from assets sale
-
-
-426.50K
-426.50K
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more